Ronald Hunt, Director, 10% Owner at Durata Therapeutics, Inc. (DRTX), bought 3,028,439 shares at $9.00 ($7.1M) on 2012-07-24, disclosed to the SEC on 2012-07-26.
Open-market purchase of $7.1M DRTX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,244,126 | $0 | 0.0% |
| 2 | $9.00 | 784,313 | $7.1M | 100.0% |
| Total | $2.33 avg | 3,028,439 | $7.1M | 100% |
| Filing → |
| HARP | BUY | 2019-02-14 | $6.0M | — | Filing → |
| ITRM | BUY | 2018-05-31 | $8.6M | — | Filing → |
| MEIP | SELL | 2014-12-10 | $476K | — | Filing → |